<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-5051</journal-id>
<journal-title><![CDATA[Innovar]]></journal-title>
<abbrev-journal-title><![CDATA[Innovar]]></abbrev-journal-title>
<issn>0121-5051</issn>
<publisher>
<publisher-name><![CDATA[Facultad de Ciencias Económicas. Universidad Nacional de Colombia.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-50512022000100153</article-id>
<article-id pub-id-type="doi">10.15446/innovar.v32n83.99922</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[La industria farmacéutica en Colombia en la literatura académica interdisciplinaria: revisión de alcance, 1990-2018]]></article-title>
<article-title xml:lang="en"><![CDATA[THE COLOMBIAN PHARMACEUTICAL INDUSTRY IN INTERDISCIPLINARY ACADEMIC LITERATURE: SCOPING REVIEW, 1990-2018]]></article-title>
<article-title xml:lang="pt"><![CDATA[A INDÚSTRIA FARMACÊUTICA NA COLÔMBIA NA LITERATURA ACADÊMICA INTERDISCIPLINAR: REVISÃO DE ESCOPO, 1990-2018]]></article-title>
<article-title xml:lang="fr"><![CDATA[L'INDUSTRIE PHARMACEUTIQUE EN COLOMBIE DANS LA LITTÉRATURE ACADÉMIQUE INTERDISCIPLINAIRE: EXAMEN DE LA PORTÉE, 1990-2018]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mendoza-Ruiz]]></surname>
<given-names><![CDATA[Adriana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[Maria Auxiliadora]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Paranhos]]></surname>
<given-names><![CDATA[Julia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Fundación Oswaldo Cruz (ENSP/FIOCRUZ)  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Fundación Oswaldo Cruz (ENSP/FIOCRUZ)  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Federal de Rio de Janeiro (IE/UFRJ)  ]]></institution>
<addr-line><![CDATA[Rio de Janeiro ]]></addr-line>
<country>Brasil</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2022</year>
</pub-date>
<volume>32</volume>
<numero>83</numero>
<fpage>153</fpage>
<lpage>174</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-50512022000100153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-50512022000100153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-50512022000100153&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN: La industria farmacéutica es un sector estratégico tanto para el desarrollo de un país como por sus interfaces con los sectores de salud, ciencia, tecnología e innovación. El objetivo de este trabajo fue analizar la literatura académica publicada sobre la industria farmacéutica en Colombia entre 1990 y 2018. Para ello, se realizó una revisión de alcance en la que, en total, 84 trabajos fueron incluidos: 71 artículos científicos y 13 documentos de literatura gris. Una tendencia al crecimiento de la literatura fue observada pero con persistencia del predominio de análisis económicos, financieros y de propiedad intelectual. Los únicos estudios sobre desarrollo tecnológico industrial farmacéutico, usando fuentes primarias, fueron publicados entre 2007 y 2010. No fueron identificados análisis centrados en ese sector usando como fuente secundaria las Encuestas de Desarrollo e Innovación Tecnológica. Aunque los estudios con abordaje histórico, organizacional y de procesos de transformación de materiales contribuyeron al conocimiento sobre algunas empresas de capital nacional, se corroboró la persistencia de la brecha en el estudio del desarrollo y la acumulación de las capacidades de innovación de los fabricantes farmacéuticos, privados y públicos, en Colombia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT: The pharmaceutical industry is strategic for the development of a country, considering its association with health, science, technology and innovation sectors. The objective of this work was to examine the academic literature focused on the Colombian pharmaceutical industry published between 1990 and 2018. To do that, we carried out a scoping review of 84 papers: 71 scientific articles and 13 gray literature documents. A trend towards the growth of related literature was observed, although economic, financial and intellectual property studies remain as the main repertoire. Findings show that the only studies addressing technological development within this industry using primary sources were published between 2007 and 2010. In addition, none of the works in the sample used the Technological Development and Innovation Surveys as a secondary source of information. Despite the fact that some studies with a historical, organizational and materials transformation process' approach contributed to the knowledge of some national companies, the persisting gap in the study of the development and accumulation of innovation capacities by pharmaceutical manufacturers, both private and public, in Colombia was confirmed.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[RESUMO: A indústria farmacêutica é um setor estratégico para o desenvolvimento de um país e por suas interfaces com os setores da saúde, da ciência, da tecnologia e da inovação. Nesse sentido, o objetivo deste trabalho é analisar a literatura acadêmica publicada sobre a indústria farmacêutica na Colômbia entre 1990 e 2018. Para isso, foi realizada uma revisão de escopo em que, em total, 84 trabalhos foram incluídos: 71 artigos científicos e 13 documentos de literatura cinzenta. Uma tendência ao crescimento da literatura foi observada, mas com persistência do predomínio de análises econômicas, financeiras e de propriedade intelectual. Os únicos estudos sobre desenvolvimento tecnológico industrial farmacêutico, usando fontes primárias, foram publicados entre 2007 e 2010. Não foram identificadas análises centralizadas nesse setor com a utilização de questionários de desenvolvimento e inovação tecnológica como fonte secundária. Embora os estudos com abordagem histórica, organizacional e de processos de transformação de materiais tenham contribuído para o conhecimento sobre algumas empresas de capital nacional, constatou-se a persistência da lacuna no estudo do desenvolvimento e no acúmulo das capacidades de inovação dos fabricantes farmacêuticos, privados e públicos, na Colômbia.]]></p></abstract>
<abstract abstract-type="short" xml:lang="fr"><p><![CDATA[RÉSUMÉ: L'industrie pharmaceutique est un secteur stratégique à la fois pour le développement d'un pays et pour ses interfaces avec les secteurs de la santé, de la science, de la technologie et de l'innovation. L'objectif de ce travail était d'analyser la littérature académique publiée sur l'industrie pharmaceutique en Colombie entre 1990 et 2018. Pour cela, on a mené une revue de la portée dans laquelle, au total, 84 articles ont été inclus : 71 articles scientifiques et 13 articles de littérature grise. On a observé une tendance à la croissance de la littérature, mais avec la persistance de la prédominance des analyses économiques, financières et de propriété intellectuelle. Les seules études sur le développement technologique de .'industrie pharmaceutique, utilisant des sources primaires, ont été publiées entre 2007 et 2010. Aucune analyse portant sur ce secteur n'a été identifiée en utilisant les enquêtes de Développement et Innovation Technologique comme source secondaire. Bien que les études avec une approche historique, organisationnelle et des processus de transformation des matériaux aient contribué à la connaissance de certaines entreprises à capital national, on a confirmé la persistance de l'écart dans l'étude du développement et de l'accumulation des capacités d'innovation des fabricants de produits pharmaceutiques, privés et publiques, en Colombie.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Colombia]]></kwd>
<kwd lng="es"><![CDATA[industria farmacéutica]]></kwd>
<kwd lng="es"><![CDATA[investigación científica y desarrollo tecnológico]]></kwd>
<kwd lng="es"><![CDATA[preparaciones farmacéuticas]]></kwd>
<kwd lng="en"><![CDATA[Colombia]]></kwd>
<kwd lng="en"><![CDATA[pharmaceutical industry]]></kwd>
<kwd lng="en"><![CDATA[scientific research and technological development]]></kwd>
<kwd lng="en"><![CDATA[pharmaceutical preparations]]></kwd>
<kwd lng="pt"><![CDATA[Colômbia]]></kwd>
<kwd lng="pt"><![CDATA[indústria farmacêutica]]></kwd>
<kwd lng="pt"><![CDATA[pesquisa científica e desenvolvimento tecnológico]]></kwd>
<kwd lng="pt"><![CDATA[preparações farmacêuticas]]></kwd>
<kwd lng="fr"><![CDATA[Colombie]]></kwd>
<kwd lng="fr"><![CDATA[industrie pharmaceutique]]></kwd>
<kwd lng="fr"><![CDATA[recherche scientifique et développement technologique]]></kwd>
<kwd lng="fr"><![CDATA[préparations pharmaceutiques]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Achilladelis]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Antonakis]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The dynamics of technological innovation: The case of the pharmaceutical industry]]></article-title>
<source><![CDATA[Research Policy]]></source>
<year>2001</year>
<volume>30</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>535-88</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinantes de la innovación: evidencia en el sector manufacturero de Bogotá]]></article-title>
<source><![CDATA[Semestre Económico]]></source>
<year>2012</year>
<volume>15</volume>
<numero>32</numero>
<issue>32</issue>
<page-range>129-60</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amariles]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Restrepo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial. El sector farmacéutico como pieza clave en la reorganización de los sistemas de salud]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2012</year>
<volume>19</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>153-5</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andia]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial. Tutelas en salud y paradoja de los medicamentos de marca versus los medicamentos genéricos en Colombia]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2013</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>93-4</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andia]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<source><![CDATA[El "efecto portafolio" de la regulación de precios de medicamentos: La respuesta de la industria farmacéutica a la regulación de precios de medicamentos en Colombia]]></source>
<year>2018</year>
<numero>1507</numero>
<issue>1507</issue>
<publisher-name><![CDATA[BID]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arboleda]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Beneficios y perjuicios de la estrategia de imitación]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2014</year>
<volume>30</volume>
<numero>131</numero>
<issue>131</issue>
<page-range>145-52</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Pinzón]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
<name>
<surname><![CDATA[Quiroz]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[La evolución de los instrumentos de política para el fomento de actividades de ciencia, tecnología e innovación (ACTI) en Colombia]]></source>
<year>2017</year>
<conf-name><![CDATA[ XVIICongreso ALTEC]]></conf-name>
<conf-loc>Ciudad de México, México </conf-loc>
</nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Las relaciones entre la industria y los demás agentes tecnológicos en los Sistemas Regionales de Innovación]]></source>
<year>2015</year>
<conf-name><![CDATA[ XVICongreso ALTEC]]></conf-name>
<conf-loc>Porto Alegre, Brasil </conf-loc>
</nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Las interacciones de la industria en los sistemas de innovación: un estudio bibliométrico]]></source>
<year>2015</year>
<conf-name><![CDATA[ XVICongreso ALTEC]]></conf-name>
<conf-loc>Porto Alegre, Brasil </conf-loc>
</nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arksey]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[O'Malley]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scoping studies: Towards a methodological framework]]></article-title>
<source><![CDATA[International Journal of Social Research Methodology]]></source>
<year>2005</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>19-32</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barona-Zuluaga]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera-Godoy]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilera-Cifuentes]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Garizado-Román]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Financiación de la innovación en Colombia]]></article-title>
<source><![CDATA[Entramado]]></source>
<year>2015</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>80-93</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barrera]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desarrollo de medicamentos biotecnológicos. Del laboratorio al paciente]]></article-title>
<source><![CDATA[Medicina]]></source>
<year>2018</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>44-55</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bayona-Velásquez]]></surname>
<given-names><![CDATA[E. M.]]></given-names>
</name>
<name>
<surname><![CDATA[Erazo-Ortiz]]></surname>
<given-names><![CDATA[D. S.]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-González]]></surname>
<given-names><![CDATA[E. F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovation in the Colombian manufacturing industry 2013-2014]]></article-title>
<source><![CDATA[Dimensión Empresarial]]></source>
<year>2017</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>15-28</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bell]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Pavitt]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Technological accumulation and industrial growth: Contrasts between developed and developing countries]]></article-title>
<source><![CDATA[Industrial and Corporate Change]]></source>
<year>1993</year>
<volume>2</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>157-210</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bermudez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Remédio: Saúde o industria? A produção de medicamentos no Brasil]]></source>
<year>1992</year>
<publisher-name><![CDATA[Relume Dumara]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Borges dos Santos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[dos Santos Dias]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Santos]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[da Silva]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Osorio-de-Castro]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Factors influencing pharmaceutical pricing. A scoping review of academic literature in health science]]></article-title>
<source><![CDATA[Journal of Pharmaceutical Policy and Practice]]></source>
<year>2019</year>
<volume>12</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>24</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Busom]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Vélez-Ospina]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovation, public support, and productivity in Colombia. A cross-industry comparison]]></article-title>
<source><![CDATA[World Development]]></source>
<year>2017</year>
<volume>99</volume>
<page-range>75-94</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castellanos]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Domínguez]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Competencias tecnológicas: bases conceptuales para el desarrollo tecnológico en Colombia]]></article-title>
<source><![CDATA[Revista Ingeniería e Investigación]]></source>
<year>2009</year>
<volume>29</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>133-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castrillón]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudio sobre bioeconomía como fuente de nuevas industrias basadas en el capital natural de Colombia. Fase 2. Anexo 5. Análisis sector farmacéutico]]></source>
<year>2018</year>
<publisher-name><![CDATA[Corporación Biointropic]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="book">
<collab>Centro de Gestão e Estudos Estratégicos</collab>
<source><![CDATA[Competências para inovar na indústria farmacêutica brasileira]]></source>
<year>2017</year>
<publisher-name><![CDATA[CCEE]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chavarro]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los departamentos de I+D y la innovación en la industria manufacturera de Colombia: análisis comparativo desde el comportamiento organizacional]]></article-title>
<source><![CDATA[Innovar]]></source>
<year>2010</year>
<volume>20</volume>
<numero>37</numero>
<issue>37</issue>
<page-range>101-15</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chaves]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement]]></article-title>
<source><![CDATA[Bulletin of the World Health Organization]]></source>
<year>2007</year>
<volume>85</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-56</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chicaiza]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fallas del mercado de la salud en Colombia: el caso de la insuficiencia renal crónica]]></article-title>
<source><![CDATA[Revista de Economía Institucional]]></source>
<year>2005</year>
<volume>7</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>191-208</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="book">
<collab>Colombia Productiva</collab>
<source><![CDATA[Plan de negocios. Sector farmacéutico]]></source>
<year>2019</year>
<publisher-name><![CDATA[Visión a 2032]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Colquhoun]]></surname>
<given-names><![CDATA[H. L.]]></given-names>
</name>
<name>
<surname><![CDATA[Levac]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[O'Brien]]></surname>
<given-names><![CDATA[K. K.]]></given-names>
</name>
<name>
<surname><![CDATA[Straus]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Tricco]]></surname>
<given-names><![CDATA[A. C.]]></given-names>
</name>
<name>
<surname><![CDATA[Perrier]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Kastner]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Moher]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Scoping reviews: Time for clarity in definition, methods, and reporting]]></article-title>
<source><![CDATA[Journal of Clinical Epidemiology]]></source>
<year>2014</year>
<volume>67</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1291-4</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="book">
<collab>Comisión Económica para América Latina y el Caribe</collab>
<source><![CDATA[Horizontes 2030: La igualdad en el centro del desarrollo sostenible]]></source>
<year>2016</year>
<publisher-name><![CDATA[CEPAL]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Conill]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Xavier]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Piola]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[da Silva]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Barros]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Báscolo]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Determinantes sociais, condicionantes e desempenho dos serviços de saúde em países da América Latina, Portugal e Espanha]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2018</year>
<volume>23</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>2171-86</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corredor]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Gestión de los derechos de propiedad intelectual en el marco de modelos de colaboración científica: una oportunidad para las instituciones públicas de investigación en Colombia]]></article-title>
<source><![CDATA[Revista La Propiedad Inmaterial]]></source>
<year>2012</year>
<volume>16</volume>
<page-range>57-76</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cortes]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Fitzgerald]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[DiFabio]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Public vaccine manufacturing capacity in the Latin American and Caribbean region: Current status and perspectives]]></article-title>
<source><![CDATA[Biologicals]]></source>
<year>2012</year>
<volume>40</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>3-14</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Demmel]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Máñez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Rochina-Barrachina]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Sanchis-Llopis]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Product and process innovation and total factor productivity: Evidence for manufacturing in four Latin American countries]]></article-title>
<source><![CDATA[Review of Development Economics]]></source>
<year>2017</year>
<volume>21</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1341-63</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="book">
<collab>Departamento Nacional de Planeación (DNP)</collab>
<article-title xml:lang=""><![CDATA[Cadena farmacéutica y medicamentos]]></article-title>
<source><![CDATA[Cadenas productivas. Estructura, comercio internacional y protección]]></source>
<year>2004</year>
<page-range>361-77</page-range><publisher-name><![CDATA[DNP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duarte]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A model of organizational learning in practice]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2013</year>
<volume>29</volume>
<numero>129</numero>
<issue>129</issue>
<page-range>439-44</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Erazo]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De lo artesanal a lo industrial. La consolidación de la industria de medicamentos en Cali (Colombia, 18761944)]]></article-title>
<source><![CDATA[Historia Crítica]]></source>
<year>2016</year>
<volume>62</volume>
<page-range>143-63</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escandón]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Arias]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Colombian pharmaceutical industry: Factors affecting export]]></article-title>
<source><![CDATA[European Journal of Management and Business Economics]]></source>
<year>2016</year>
<volume>25</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>39-46</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escobar]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Los planes estratégicos para el desarrollo de la ciencia, la tecnológica y la innovación como herramienta hacia la competitividad regional y su real impacto]]></source>
<year>2015</year>
<conf-name><![CDATA[ XVICongreso ALTEC]]></conf-name>
<conf-loc>Porto Alegre, Brasil </conf-loc>
</nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falqueto]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Kligerman]]></surname>
<given-names><![CDATA[D. C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diretrizes para um programa de recolhimento de medicamentos vencidos no Brasil]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2013</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>883-92</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aprendizagem tecnológica e inovação industrial em economias emergentes: uma breve contribuição para o desenho e implementação de estudos empíricos e estratégias no Brasil]]></article-title>
<source><![CDATA[Revista Brasileira de Inovação]]></source>
<year>2004</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>323-61</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Figueiredo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Capacidades tecnológicas e inovação. Conceitos básicos]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Figuiredo]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<source><![CDATA[Gestão da inovação. Conceitos métricas e experiências de empresas no Brasil]]></source>
<year>2009</year>
<page-range>15-43</page-range><publisher-name><![CDATA[LTC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forero-Pineda]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Laureiro-Martinez]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Innovation patterns and intellectual property in SMEs of a developing country]]></article-title>
<source><![CDATA[Innovar]]></source>
<year>2011</year>
<volume>21</volume>
<numero>42</numero>
<issue>42</issue>
<page-range>113-27</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franco]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El Área de Libre Comercio-ALCA y el sector salud en América Latina]]></article-title>
<source><![CDATA[Revista de Salud Pública]]></source>
<year>2003</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-17</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Franculino]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Gomes]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Hasenclever]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Política industrial e redes de comércio de medicamentos: os casos do Brasil, Irlanda e Índia no período 1995 a 2015]]></article-title>
<source><![CDATA[Blucher Engineering Proceedings]]></source>
<year>2018</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progreso técnico y poder de mercado en la industria farmacéutica]]></article-title>
<source><![CDATA[DYNA]]></source>
<year>2009</year>
<volume>76</volume>
<numero>159</numero>
<issue>159</issue>
<page-range>93-102</page-range></nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Plazas]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La capacidad de manufactura como un indicador de desarrollo tecnológico en el sector farmacéutico industrial]]></article-title>
<source><![CDATA[Ingenieria e Investigación]]></source>
<year>2010</year>
<volume>30</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>112-7</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[O.]]></given-names>
</name>
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La calidad desde el diseño: principios y oportunidades para la industria farmacéutica]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2015</year>
<volume>31</volume>
<numero>134</numero>
<issue>134</issue>
<page-range>68-78</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accidentes terapéuticos y nuevas prácticas de salud. La medicina colombiana frente a la catástrofe de la vacunación antidiftérica en Medellín, 1930]]></article-title>
<source><![CDATA[Historia Critica]]></source>
<year>2012</year>
<volume>46</volume>
<page-range>110-31</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los medicamentos genéricos en Colombia: industria, políticas de salud y farmaceutización durante la década de 1960]]></article-title>
<source><![CDATA[Historia Crítica]]></source>
<year>2017</year>
<volume>65</volume>
<page-range>115-37</page-range></nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García-Pérez]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Gálvez-Albarracín]]></surname>
<given-names><![CDATA[E. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado-Guzmán]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efecto de la innovación en el crecimiento y el desempeño de las mipymes de la Alianza del Pacífico. Un estudio empírico]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2016</year>
<volume>32</volume>
<numero>141</numero>
<issue>141</issue>
<page-range>326-35</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gereffi]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los oligopolios internacionales, el Estado y el desarrollo industrial en Mexico: el caso de la industria de hormonas esteroides]]></article-title>
<source><![CDATA[Foro Internacional]]></source>
<year>1977</year>
<volume>17</volume>
<numero>68</numero>
<issue>68</issue>
<page-range>490-541</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gereffi]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Producción y comercialización de medicamentos básicos en América Latina y el Caribe. Algunas experiencias nacionales y subregionales]]></article-title>
<source><![CDATA[Comercio Exterior]]></source>
<year>1983</year>
<volume>33</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1008-17</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Robledo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<source><![CDATA[Evolución de las capacidades de innovación en la industria colombiana: Un análisis comparativo de los resultados de las encuestas de innovación de 1996 y 2005]]></source>
<year>2011</year>
<conf-name><![CDATA[ XIVCongreso ALTEC]]></conf-name>
<conf-loc>Lima, Perú </conf-loc>
</nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez-Cardona]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Cabal]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez-Cabal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sueros antiofídicos en Colombia: análisis de la producción, abastecimiento y recomendaciones para el mejoramiento de la red de producción]]></article-title>
<source><![CDATA[Biosalud]]></source>
<year>2017</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>96-116</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[López]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Araujo]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Los ADPIC plus en los actuales tratados bilaterales impulsados por Estados Unidos y consecuencias en los países en desarrollo]]></article-title>
<source><![CDATA[Revista de Economía Mundial]]></source>
<year>2008</year>
<volume>20</volume>
<page-range>23-48</page-range></nlm-citation>
</ref>
<ref id="B53">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Jaime]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<source><![CDATA[El patentamiento universitario en Colombia]]></source>
<year>2011</year>
<conf-name><![CDATA[ XIVCongreso ALTEC]]></conf-name>
<conf-loc>Lima, Perú </conf-loc>
</nlm-citation>
</ref>
<ref id="B54">
<nlm-citation citation-type="">
<collab>Grey Literature Network Service</collab>
<source><![CDATA[Declaración de PISA. Desarrollo de políticas para el manejo de la literatura gris]]></source>
<year>2014</year>
</nlm-citation>
</ref>
<ref id="B55">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guevara]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Luengas]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Garavito]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Revisión documental de los productos naturales legalmente autorizados para su mercadeo en Colombia]]></article-title>
<source><![CDATA[Colombia Médica]]></source>
<year>2010</year>
<volume>41</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>129-40</page-range></nlm-citation>
</ref>
<ref id="B56">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guinard]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discussing the tension between states' right to regulate and foreign investment protection in recent Colombian cases]]></article-title>
<source><![CDATA[Contexto]]></source>
<year>2017</year>
<volume>47</volume>
<page-range>89-119</page-range></nlm-citation>
</ref>
<ref id="B57">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial. Planta de producción de medicamentos esenciales y afines. Certificación en buenas prácticas de manufactura]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2001</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-2</page-range></nlm-citation>
</ref>
<ref id="B58">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Guzmán]]></surname>
<given-names><![CDATA[M. V.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[¿Poseen capacidades de innovación las empresas farmacéuticas de América Latina? La evidencia de Argentina, Brasil, Cuba y México]]></article-title>
<source><![CDATA[Economía: Teoría y Práctica]]></source>
<year>2009</year>
<volume>1</volume>
<page-range>131-73</page-range></nlm-citation>
</ref>
<ref id="B59">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Helfer]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Alter]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Guerzovich]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Islands of effective international adjudication: Constructing an intellectual property rule of law in the Andean Community]]></article-title>
<source><![CDATA[American Journal of International Law]]></source>
<year>2009</year>
<volume>103</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-47</page-range></nlm-citation>
</ref>
<ref id="B60">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Multisource drug policies in Latin America: survey of 10 countries]]></article-title>
<source><![CDATA[Bulletin of the World Health Organization]]></source>
<year>2005</year>
<volume>83</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>64-70</page-range></nlm-citation>
</ref>
<ref id="B61">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Homedes]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Ugalde]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted]]></article-title>
<source><![CDATA[Bulletin of the World Health Organization]]></source>
<year>2015</year>
<volume>93</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>674-83</page-range></nlm-citation>
</ref>
<ref id="B62">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estructura de la inversión en actividades de la industria manufacturera colombiana en actividades de innovación y desarrollo tecnológico]]></article-title>
<source><![CDATA[Innovar]]></source>
<year>2014</year>
<volume>24</volume>
<numero>^sEspecial</numero>
<issue>^sEspecial</issue>
<supplement>Especial</supplement>
<page-range>33-40</page-range></nlm-citation>
</ref>
<ref id="B63">
<nlm-citation citation-type="">
<collab>Invest in Bogotá</collab>
<source><![CDATA[Bogotá-región, el centro estratégico para la industria farmacéutica]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B64">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Iñesta]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Oteo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La industria farmacéutica y la sostenibilidad de los sistemas de salud en países desarrollados y América Latina]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2011</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2713-24</page-range></nlm-citation>
</ref>
<ref id="B65">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial. Facultad de Química Farmacéutica, 60 años de calidad y liderazgo]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2003</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>5-7</page-range></nlm-citation>
</ref>
<ref id="B66">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Hurtado]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La concentración de mercado en el sector farmacéutico colombiano 2002-2003. Un análisis parcial para las enfermedades cerebrovasculares e isquemias, diabetes mellitus y morbimortalidad cardiovascular]]></article-title>
<source><![CDATA[Ecos de Economía]]></source>
<year>2005</year>
<volume>9</volume>
<numero>21</numero>
<issue>21</issue>
<page-range>173-202</page-range></nlm-citation>
</ref>
<ref id="B67">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Juliao]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Barrios]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Schmutzler]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relación entre la estrategia de innovación de la firma y su decisión de patentar: evidencia de empresas pertenecientes al sector manufacturero colombiano]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2013</year>
<volume>29</volume>
<numero>128</numero>
<issue>128</issue>
<page-range>313-21</page-range></nlm-citation>
</ref>
<ref id="B68">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Burachik]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Brodovsky]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Queiroz]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<source><![CDATA[Apertura económica y desregulación en el mercado de medicamentos: la industria farmacéutica y farmoquímica en Argentina, Brasil y México en los años 90]]></source>
<year>1997</year>
<publisher-loc><![CDATA[CEPAL ]]></publisher-loc>
<publisher-name><![CDATA[Alianza Editorial]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B69">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kornis]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Braga]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Paula]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transformações recentes da indústria farmacêutica: um exame da experiência mundial e brasileira no século XXI]]></article-title>
<source><![CDATA[Physis. Revista de Saúde Coletiva]]></source>
<year>2014</year>
<volume>24</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>885-908</page-range></nlm-citation>
</ref>
<ref id="B70">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Londoño]]></surname>
<given-names><![CDATA[J.-L.]]></given-names>
</name>
<name>
<surname><![CDATA[Frenk]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Structured pluralism: Towards an innovative model for health system reform in Latin America]]></article-title>
<source><![CDATA[Health Policy]]></source>
<year>1997</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-36</page-range></nlm-citation>
</ref>
<ref id="B71">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Losada-Otálora]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Zuluaga]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Derramamientos sectoriales de conocimiento e innovación en la industria manufacturera colombiana: Un análisis multinivel]]></article-title>
<source><![CDATA[Innovar]]></source>
<year>2013</year>
<volume>23</volume>
<numero>47</numero>
<issue>47</issue>
<page-range>19-32</page-range></nlm-citation>
</ref>
<ref id="B72">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malaver]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La competitividad de la industria colombiana. Un balance de su evolución en los años noventa]]></article-title>
<source><![CDATA[Innovar]]></source>
<year>2001</year>
<volume>17</volume>
<page-range>67-88</page-range></nlm-citation>
</ref>
<ref id="B73">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malaver]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Políticas y avances en la ciencia, la tecnología y la innovación en Colombia 1990-2005]]></article-title>
<source><![CDATA[Cuadernos de Administración]]></source>
<year>2005</year>
<volume>18</volume>
<numero>30</numero>
<issue>30</issue>
<page-range>39-78</page-range></nlm-citation>
</ref>
<ref id="B74">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malaver]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Formas de innovar y sus implicaciones de política: Lecciones de una experiencia]]></article-title>
<source><![CDATA[Cuadernos de Economía]]></source>
<year>2013</year>
<volume>32</volume>
<numero>60</numero>
<issue>60</issue>
<page-range>499-532</page-range></nlm-citation>
</ref>
<ref id="B75">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malerba]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Orsenigo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The evolution of the pharmaceutical industry]]></article-title>
<source><![CDATA[Business History]]></source>
<year>2015</year>
<volume>57</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>664-87</page-range></nlm-citation>
</ref>
<ref id="B76">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las patentes en la industria farmacéutica: entre la ética y los derechos de propiedad]]></article-title>
<source><![CDATA[Revista de Salud Pública]]></source>
<year>2003</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-23</page-range></nlm-citation>
</ref>
<ref id="B77">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McKelvey]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Orsenigo]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Pammolli]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmaceuticals analyzed through the lens of a sectoral innovation system]]></article-title>
<source><![CDATA[Sectoral systems of innovation: Concepts, issues and analyses of six major sectors in Europe]]></source>
<year>2004</year>
<page-range>73120</page-range><publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B78">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Editorial. La biodiversidad y la biotecnología en la Facultad de Química Farmacéutica de la Universidad de Antioquia, a propósito del Documento CONPES 3697 de 2011]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2011</year>
<volume>18</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>111-3</page-range></nlm-citation>
</ref>
<ref id="B79">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mejía]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Cuellar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Cobo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Shepard]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Benavides]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<source><![CDATA[usiness networks in the Colombian pharmaceutical industry]]></source>
<year>2017</year>
<conf-name><![CDATA[ XVIICongreso ALTEC]]></conf-name>
<conf-loc>Ciudad de México, México </conf-loc>
</nlm-citation>
</ref>
<ref id="B80">
<nlm-citation citation-type="book">
<collab>Ministerio de Comercio</collab>
<collab>Industria y Turismo</collab>
<source><![CDATA[Perfiles económicos y comerciales]]></source>
<year>2019</year>
<publisher-name><![CDATA[Mincomercio]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B81">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moncayo]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Las políticas regionales de ciencia, tecnología e innovación en Colombia: surgimiento, evolución y balance de la situación actual]]></article-title>
<source><![CDATA[OPERA]]></source>
<year>2018</year>
<volume>23</volume>
<page-range>185-208</page-range></nlm-citation>
</ref>
<ref id="B82">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Montoya]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Planta de medicamentos UdeA, líder en buenas prácticas]]></source>
<year>2019</year>
<month>,</month>
<publisher-name><![CDATA[UdeA Noticias]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B83">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mora]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Interrelaciones entre las empresas multinacionales y las firmas locales farmacéuticas. Impacto en el desarrollo industrial de este sector en Colombia]]></source>
<year>2003</year>
<publisher-name><![CDATA[Universidad Nacional de Colombia]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B84">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<source><![CDATA[Visión histórica de la farmacia en Colombia]]></source>
<year>2006</year>
<publisher-name><![CDATA[Grupo Editorial APSIS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B85">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munn]]></surname>
<given-names><![CDATA[Z.]]></given-names>
</name>
<name>
<surname><![CDATA[Peters]]></surname>
<given-names><![CDATA[M. D. J.]]></given-names>
</name>
<name>
<surname><![CDATA[Stern]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Tufanaru]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[McArthur]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Aromataris]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach]]></article-title>
<source><![CDATA[BMC Medical Research Methodology]]></source>
<year>2018</year>
<volume>18</volume>
<page-range>143</page-range></nlm-citation>
</ref>
<ref id="B86">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Niosi]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[McKelvey]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relating business model innovations and innovation cascades: The case of biotechnology]]></article-title>
<source><![CDATA[Journal of Evolutionary Economics]]></source>
<year>2018</year>
<volume>28</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1081-109</page-range></nlm-citation>
</ref>
<ref id="B87">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ochoa]]></surname>
<given-names><![CDATA[H.]]></given-names>
</name>
<name>
<surname><![CDATA[Correa]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Atehortúa]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Proceso de internacio-nalización en el sector farmacéutico: el caso de la empresa colombiana Tecnoquímicas]]></article-title>
<source><![CDATA[Estudios Gerenciales]]></source>
<year>2017</year>
<volume>33</volume>
<numero>145</numero>
<issue>145</issue>
<page-range>421-37</page-range></nlm-citation>
</ref>
<ref id="B88">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Zepeda]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Chaves]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Velásquez]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?]]></article-title>
<source><![CDATA[Bulletin of the World Health Organization]]></source>
<year>2004</year>
<volume>82</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>815-21</page-range></nlm-citation>
</ref>
<ref id="B89">
<nlm-citation citation-type="book">
<collab>Organización de las Naciones Unidas para el Desarrollo Industrial</collab>
<source><![CDATA[Informe sobre el desarrollo industrial 2018. Demanda de manufacturas: impulsando el desarrollo industrial inclusivo y sostenible. Resumen]]></source>
<year>2017</year>
<publisher-name><![CDATA[ONUDI]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B90">
<nlm-citation citation-type="">
<collab>Organización Mundial de la Salud</collab>
<collab>Organización Mundial de la Propiedad Intelectual</collab>
<collab>Organización Mundial del Comercio</collab>
<source><![CDATA[Promover el acceso a las tecnologías médicas y la innovación. Intersecciones entre la salud pública, la propiedad intelectual y el comercio]]></source>
<year>2013</year>
</nlm-citation>
</ref>
<ref id="B91">
<nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<article-title xml:lang=""><![CDATA[Factores determinantes en la calidad de los medicamentos y aspectos regulatorios asociados]]></article-title>
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Guía para la implementación de estrategias de medicamentos genéricos en los países de América Latina y el Caribe como mecanismo para mejorar el acceso a medicamentos]]></source>
<year>2011</year>
<page-range>49-56</page-range><publisher-name><![CDATA[OPS/OMS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B92">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Osorio]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lo que todos debemos saber de las buenas prácticas clínicas]]></article-title>
<source><![CDATA[Biomédica]]></source>
<year>2015</year>
<volume>35</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>274-84</page-range></nlm-citation>
</ref>
<ref id="B93">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Paranhos]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Hansenclever]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Empresa inovadora: Teoria, conceitos e métricas]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Rapini]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Ruffoni]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Albuquerque]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<source><![CDATA[Economia da ciência, tecnologia e inovação: Fundamentos teóricos e a economia global]]></source>
<year>2021</year>
<page-range>161-82</page-range><publisher-loc><![CDATA[Cedeplar ]]></publisher-loc>
<publisher-name><![CDATA[UFMG]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B94">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parisi]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Cairatti]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Fortalecimiento de la Red Panamericana de Laboratorios Oficiales de Control de Medicamentos]]></article-title>
<source><![CDATA[Revista Panamericana de Salud Pública]]></source>
<year>2016</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>255-61</page-range></nlm-citation>
</ref>
<ref id="B95">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pertuz]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Educación, ciencia, tecnología e innovación en Colombia: avances y retos del periodo 1996-2016]]></article-title>
<source><![CDATA[Revista Andina de Estudios Políticos]]></source>
<year>2016</year>
<volume>6</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>92-116</page-range></nlm-citation>
</ref>
<ref id="B96">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Prada]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Andia]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
<name>
<surname><![CDATA[Vaca]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Morales]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
<name>
<surname><![CDATA[Márquez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Gaviria]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Higher pharmaceutical public expenditure after direct price control: Improved access or induced demand? The Colombian case]]></article-title>
<source><![CDATA[Cost Effectiveness and Resource Allocation]]></source>
<year>2018</year>
<volume>16</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B97">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Reinel]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La estrategia Uribe de negociación del TLC]]></article-title>
<source><![CDATA[Colombia Internacional]]></source>
<year>2005</year>
<volume>61</volume>
<page-range>12-32</page-range></nlm-citation>
</ref>
<ref id="B98">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Robledo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Malaver]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Encuestas, datos y descubrimiento de conocimiento sobre la innovación en Colombia]]></source>
<year>2009</year>
<publisher-name><![CDATA[Javegraf]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B99">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanabria]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Progreso tecnológico y divergencias regionales: evidencia para Colombia (1980-2010)]]></article-title>
<source><![CDATA[Investigaciones Regionales -Journal of Regional Research]]></source>
<year>2017</year>
<volume>38</volume>
<page-range>7-25</page-range></nlm-citation>
</ref>
<ref id="B100">
<nlm-citation citation-type="confpro">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sierra]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Becerra]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<source><![CDATA[Contribución de las redes empresariales de cooperación entre pymes para el desarrollo económico regional]]></source>
<year>2011</year>
<conf-name><![CDATA[ XIVCongreso ALTEC]]></conf-name>
<conf-loc>Lima, Perú </conf-loc>
</nlm-citation>
</ref>
<ref id="B101">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El proceso de negociación del TLC entre Colombia y Estados Unidos]]></article-title>
<source><![CDATA[Colombia Internacional]]></source>
<year>2007</year>
<volume>65</volume>
<page-range>112-33</page-range></nlm-citation>
</ref>
<ref id="B102">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Storpirtis]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<name>
<surname><![CDATA[Gai]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Cristofoletti]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Generic and similar products in Latin American countries: Current aspects and perspectives on bioequivalence and biowaivers]]></article-title>
<source><![CDATA[Pharmaceuticals, Policy and Law]]></source>
<year>2014</year>
<volume>16</volume>
<numero>3-4</numero>
<issue>3-4</issue>
<page-range>225-48</page-range></nlm-citation>
</ref>
<ref id="B103">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Temprano]]></surname>
<given-names><![CDATA[G.]]></given-names>
</name>
<name>
<surname><![CDATA[Aprea]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
<name>
<surname><![CDATA[Dokmetjian]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La producción pública de antivenenos en la Región de las Américas como factor clave de su accesibilidad]]></article-title>
<source><![CDATA[Revista Panamericana de Salud Pública]]></source>
<year>2017</year>
<volume>41</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B104">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tobar]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Drake]]></surname>
<given-names><![CDATA[I.]]></given-names>
</name>
<name>
<surname><![CDATA[Martich]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Alternativas para la adopción de políticas centradas en el acceso a medicamentos]]></article-title>
<source><![CDATA[Revista Panamericana de Salud Pública]]></source>
<year>2012</year>
<volume>32</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>457-63</page-range></nlm-citation>
</ref>
<ref id="B105">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Turriago]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Some aspects of technological innovation and innovation activities in Colombia. Comparison with three Latin American countries]]></article-title>
<source><![CDATA[Cuadernos de Administración]]></source>
<year>2003</year>
<volume>16</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>173-94</page-range></nlm-citation>
</ref>
<ref id="B106">
<nlm-citation citation-type="book">
<collab>United Nations Conference on Trade and Development</collab>
<source><![CDATA[Using intellectual property rights to stimulate pharmaceutical production in developing countries: A reference guide]]></source>
<year>2011</year>
<publisher-name><![CDATA[UNCTAD]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B107">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[La falacia de los datos de prueba]]></article-title>
<source><![CDATA[Revista La Propiedad Inmaterial]]></source>
<year>2012</year>
<volume>16</volume>
<page-range>57-76</page-range></nlm-citation>
</ref>
<ref id="B108">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uribe]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impatentabilidad de medicamentos esenciales]]></article-title>
<source><![CDATA[Revista La Propiedad Inmaterial]]></source>
<year>2014</year>
<volume>18</volume>
<page-range>55-84</page-range></nlm-citation>
</ref>
<ref id="B109">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vaca]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Discussants. Ensuring access; halting pressures!]]></article-title>
<source><![CDATA[Ciência &amp; Saúde Coletiva]]></source>
<year>2017</year>
<volume>22</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>2446-9</page-range></nlm-citation>
</ref>
<ref id="B110">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vacca]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Fitzgerald]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Bermúdez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Definición de medicamento genérico ¿un fin o un medio? Análisis de la regulación en 14 países de la Región de las Américas]]></article-title>
<source><![CDATA[Revista Panamericana de Salud Pública]]></source>
<year>2006</year>
<volume>20</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>314-23</page-range></nlm-citation>
</ref>
<ref id="B111">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vacca]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
<name>
<surname><![CDATA[Cañas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Reveiz]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Publicidad y promoción de medicamentos: regulaciones y grado de acatamiento en cinco países de América Latina]]></article-title>
<source><![CDATA[Revista Panamericana de Salud Pública]]></source>
<year>2011</year>
<volume>29</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>6-83</page-range></nlm-citation>
</ref>
<ref id="B112">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Desarrollo tecnológico del sector farmacéutico industrial asociado a procesos de transformación de materiales]]></article-title>
<source><![CDATA[Vitae]]></source>
<year>2007</year>
<volume>14</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>59-70</page-range></nlm-citation>
</ref>
<ref id="B113">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Olaya]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio descriptivo de los operadores logísticos como componentes estratégicos dentro de la cadena de valor del medicamento en Bogotá]]></article-title>
<source><![CDATA[Revista Colombiana de Ciencias Químico-Farmacéuticas]]></source>
<year>2010</year>
<volume>39</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>168-87</page-range></nlm-citation>
</ref>
<ref id="B114">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Plazas]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propuesta de una metodología para el estudio de competencia tecnológica, en empresas fabricantes de medicamentos]]></article-title>
<source><![CDATA[Universidad &amp; Empresa]]></source>
<year>2016</year>
<volume>18</volume>
<numero>31</numero>
<issue>31</issue>
<page-range>11-27</page-range></nlm-citation>
</ref>
<ref id="B115">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[N.]]></given-names>
</name>
<name>
<surname><![CDATA[Rivera]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Carvajal]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Bolívar]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estudio descriptivo de los subsectores productores y comercializadores de medicamentos y fitoterapéuticos en Bogotá]]></article-title>
<source><![CDATA[Revista Colombiana de Ciencias Químico-Farmacéuticas]]></source>
<year>2007</year>
<volume>36</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>175-91</page-range></nlm-citation>
</ref>
<ref id="B116">
<nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vargas]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Malaver]]></surname>
<given-names><![CDATA[F.]]></given-names>
</name>
<name>
<surname><![CDATA[Zerda]]></surname>
<given-names><![CDATA[Á.]]></given-names>
</name>
</person-group>
<source><![CDATA[La innovación tecnológica en la industria colombiana: un estudio en dos cadenas industriales]]></source>
<year>2003</year>
<publisher-name><![CDATA[CEJA-OCyT-Colciencias]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B117">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vásquez]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Gómez]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Regulación en el mercado farmacéutico colombiano]]></article-title>
<source><![CDATA[Revista de Ciencias Sociales]]></source>
<year>2010</year>
<volume>16</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>197-209</page-range></nlm-citation>
</ref>
<ref id="B118">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wirtz]]></surname>
<given-names><![CDATA[V.]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera-Patino]]></surname>
<given-names><![CDATA[J.]]></given-names>
</name>
<name>
<surname><![CDATA[Santa-Ana-Tellez]]></surname>
<given-names><![CDATA[Y.]]></given-names>
</name>
<name>
<surname><![CDATA[Dreser]]></surname>
<given-names><![CDATA[A.]]></given-names>
</name>
<name>
<surname><![CDATA[Elseviers]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
<name>
<surname><![CDATA[Vander]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Analysing policy interventions to prohibit over-the-counter antibiotic sales in four Latin American countries]]></article-title>
<source><![CDATA[Tropical Medicine &amp; International Health]]></source>
<year>2013</year>
<volume>18</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>665-73</page-range></nlm-citation>
</ref>
<ref id="B119">
<nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<article-title xml:lang=""><![CDATA[United Nations Conference on Trade and Development, &amp; International Center for Trade and Sustainable Development]]></article-title>
<source><![CDATA[Local production and access to medicines in low and middle-income countries. A literature review and critical analysis]]></source>
<year>2011</year>
<month>a</month>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B120">
<nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<article-title xml:lang=""><![CDATA[United Nations Conference on Trade and Development, &amp; International Center for Trade and Sustainable Development.]]></article-title>
<source><![CDATA[Local production of Pharmaceuticals and related technology transfer in Developing Countries. A series of case studies by the UNCTAD Secretariat]]></source>
<year>2011</year>
<month>b</month>
<page-range>89-136</page-range><publisher-name><![CDATA[United Nations]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B121">
<nlm-citation citation-type="book">
<collab>World Health Organization (WHO)</collab>
<article-title xml:lang=""><![CDATA[United Nations Conference on Trade and Development, &amp; International Center for Trade and Sustainable Development]]></article-title>
<source><![CDATA[Pharmaceutical production and related technology transfer]]></source>
<year>2011</year>
<month>c</month>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
